labetalol has been researched along with Depressive Disorder in 5 studies
Labetalol: A salicylamide derivative that is a non-cardioselective blocker of BETA-ADRENERGIC RECEPTORS and ALPHA-1 ADRENERGIC RECEPTORS.
labetalol : A diastereoisomeric mixture of approximately equal amounts of all four possible stereoisomers ((R,S)-labetolol, (S,R)-labetolol, (S,S)-labetalol and (R,R)-labetalol). It is an adrenergic antagonist used to treat high blood pressure.
2-hydroxy-5-{1-hydroxy-2-[(4-phenylbutan-2-yl)amino]ethyl}benzamide : A member of the class of benzamides that is benzamide substituted by a hydroxy group at position 2 and by a 1-hydroxy-2-[(4-phenylbutan-2-yl)amino]ethyl group at position 5.
Depressive Disorder: An affective disorder manifested by either a dysphoric mood or loss of interest or pleasure in usual activities. The mood disturbance is prominent and relatively persistent.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Labetalol, a drug with alpha- and beta-adrenergic receptor blocking effects, was used to attenuate hypertension and tachycardia associated with electroconvulsive therapy (ECT) in a series of 11 elderly patients with refractory depression and cardiovascular disease in a placebo-controlled, double-blind crossover study design." | 5.06 | Labetalol in the control of cardiovascular responses to electroconvulsive therapy in high-risk depressed medical patients. ( Cooper, R; Gladson, M; Knos, G; Markwalter, H; Morris, R; Stoudemire, A; Sung, YF, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Stoudemire, A | 3 |
| Figiel, GS | 1 |
| McDonald, L | 1 |
| LaPlante, R | 1 |
| Knos, G | 1 |
| Gladson, M | 1 |
| Markwalter, H | 1 |
| Sung, YF | 1 |
| Morris, R | 1 |
| Cooper, R | 1 |
1 trial available for labetalol and Depressive Disorder
| Article | Year |
|---|---|
Labetalol in the control of cardiovascular responses to electroconvulsive therapy in high-risk depressed medical patients.
Topics: Aged; Arrhythmias, Cardiac; Blood Pressure; Cardiovascular Diseases; Depressive Disorder; Double-Bli | 1990 |
4 other studies available for labetalol and Depressive Disorder
| Article | Year |
|---|---|
Cardiovascular morbidity and ECT.
Topics: Arrhythmias, Cardiac; Cardiovascular Diseases; Comorbidity; Depressive Disorder; Drug Therapy, Combi | 1995 |
Cardiovascular complications of ECT.
Topics: Cardiovascular Diseases; Depressive Disorder; Electroconvulsive Therapy; Humans; Hypertension; Labet | 1994 |
Cardiovascular complications of ECT.
Topics: Age Factors; Aged; Cardiovascular Diseases; Delirium; Depressive Disorder; Electroconvulsive Therapy | 1994 |
Labetalol and ECT.
Topics: Age Factors; Aged; Coronary Disease; Depressive Disorder; Electroconvulsive Therapy; Humans; Hyperte | 1991 |